Current Perspectives on Gastric Cancer

Juan M. Marqués-Lespier; María González-Pons; Marcia Cruz-Correa

doi:10.1016/j.gtc.2016.04.002

Current Perspectives on Gastric Cancer

Juan M. Marqués-Lespier, María González-Pons, Marcia Cruz-Correa

Research output: Contribution to journal › Review article › peer-review

47 Scopus citations

Abstract

Gastric cancer (GC) is third leading cause of cancer-related death. Only 28.3% of new GC cases survive more than 5 years. Although incidence has declined in the United States, an increase is estimated for 2016. Risk factors include sex (risk is higher in men), Helicobacter pylori infection, heredity, and lifestyle. GC is usually diagnosed between the ages of 60–80 years. Prognosis of GC is largely dependent on the tumor stage at diagnosis and classification as intestinal or diffuse type; diffuse-type GC has worse prognosis. Chemoprevention has been shown to decrease risk, but is currently not used clinically.

Original language	English (US)
Pages (from-to)	413-428
Number of pages	16
Journal	Gastroenterology Clinics of North America
Volume	45
Issue number	3
DOIs	https://doi.org/10.1016/j.gtc.2016.04.002
State	Published - Sep 1 2016
Externally published	Yes

Keywords

Atrophic gastritis
Dysplasia
Gastric cancer
Helicobacter pylori
Intestinal metaplasia

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1016/j.gtc.2016.04.002

Cite this

@article{39bcf75cf3d64164bc0eb738de9ab6a0,

title = "Current Perspectives on Gastric Cancer",

abstract = "Gastric cancer (GC) is third leading cause of cancer-related death. Only 28.3% of new GC cases survive more than 5 years. Although incidence has declined in the United States, an increase is estimated for 2016. Risk factors include sex (risk is higher in men), Helicobacter pylori infection, heredity, and lifestyle. GC is usually diagnosed between the ages of 60–80 years. Prognosis of GC is largely dependent on the tumor stage at diagnosis and classification as intestinal or diffuse type; diffuse-type GC has worse prognosis. Chemoprevention has been shown to decrease risk, but is currently not used clinically.",

keywords = "Atrophic gastritis, Dysplasia, Gastric cancer, Helicobacter pylori, Intestinal metaplasia",

author = "Marqu{\'e}s-Lespier, {Juan M.} and Mar{\'i}a Gonz{\'a}lez-Pons and Marcia Cruz-Correa",

year = "2016",

month = sep,

day = "1",

doi = "10.1016/j.gtc.2016.04.002",

language = "English (US)",

volume = "45",

pages = "413--428",

journal = "Gastroenterology Clinics of North America",

issn = "0889-8553",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Current Perspectives on Gastric Cancer

AU - Marqués-Lespier, Juan M.

AU - González-Pons, María

AU - Cruz-Correa, Marcia

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Gastric cancer (GC) is third leading cause of cancer-related death. Only 28.3% of new GC cases survive more than 5 years. Although incidence has declined in the United States, an increase is estimated for 2016. Risk factors include sex (risk is higher in men), Helicobacter pylori infection, heredity, and lifestyle. GC is usually diagnosed between the ages of 60–80 years. Prognosis of GC is largely dependent on the tumor stage at diagnosis and classification as intestinal or diffuse type; diffuse-type GC has worse prognosis. Chemoprevention has been shown to decrease risk, but is currently not used clinically.

AB - Gastric cancer (GC) is third leading cause of cancer-related death. Only 28.3% of new GC cases survive more than 5 years. Although incidence has declined in the United States, an increase is estimated for 2016. Risk factors include sex (risk is higher in men), Helicobacter pylori infection, heredity, and lifestyle. GC is usually diagnosed between the ages of 60–80 years. Prognosis of GC is largely dependent on the tumor stage at diagnosis and classification as intestinal or diffuse type; diffuse-type GC has worse prognosis. Chemoprevention has been shown to decrease risk, but is currently not used clinically.

KW - Atrophic gastritis

KW - Dysplasia

KW - Gastric cancer

KW - Helicobacter pylori

KW - Intestinal metaplasia

UR - http://www.scopus.com/inward/record.url?scp=84991270003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991270003&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2016.04.002

DO - 10.1016/j.gtc.2016.04.002

M3 - Review article

C2 - 27546840

AN - SCOPUS:84991270003

SN - 0889-8553

VL - 45

SP - 413

EP - 428

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

IS - 3

ER -

Current Perspectives on Gastric Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this